Telomeres and Cancer: From Crisis to Stability to Crisis to Stability

Slides:



Advertisements
Similar presentations
SOD1 Integrates Signals from Oxygen and Glucose to Repress Respiration Amit R. Reddi, Valeria C. Culotta Cell Volume 152, Issue 1, Pages (January.
Advertisements

Individualized Medicine from Prewomb to Tomb Eric J. Topol Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell Copyright.
The RAG Recombinase Dictates Functional Heterogeneity and Cellular Fitness in Natural Killer Cells Jenny M. Karo, David G. Schatz, Joseph C. Sun Cell Volume.
What We Talk About When We Talk About Fat Evan D. Rosen, Bruce M. Spiegelman Cell Volume 156, Issue 1, Pages (January 2014) DOI: /j.cell
Maintaining Cell Identity through Global Control of Genomic Organization Gioacchino Natoli Immunity Volume 33, Issue 1, Pages (July 2010) DOI: /j.immuni
Genome-wide Single-Cell Analysis of Recombination Activity and De Novo Mutation Rates in Human Sperm Jianbin Wang, H. Christina Fan, Barry Behr, Stephen.
Eph-Ephrin Bidirectional Signaling in Physiology and Disease Elena B. Pasquale Cell Volume 133, Issue 1, Pages (April 2008) DOI: /j.cell
Xenobiotics Shape the Physiology and Gene Expression of the Active Human Gut Microbiome Corinne Ferrier Maurice, Henry Joseph Haiser, Peter James Turnbaugh.
Cancer Metabolism Cell Volume 148, Issue 3, (February 2012) DOI: /j.cell Copyright © 2012 Terms and Conditions Terms and Conditions.
Telomeric Noncoding RNA TERRA Is Induced by Telomere Shortening to Nucleate Telomerase Molecules at Short Telomeres Emilio Cusanelli, Carmina Angelica.
RTEL1 Dismantles T Loops and Counteracts Telomeric G4-DNA to Maintain Telomere Integrity Jean-Baptiste Vannier, Visnja Pavicic-Kaltenbrunner, Mark I.R.
The Monarch Butterfly Genome Yields Insights into Long-Distance Migration Shuai Zhan, Christine Merlin, Jeffrey L. Boore, Steven M. Reppert Cell Volume.
Evolution of the Cancer Stem Cell Model Antonija Kreso, John E. Dick Cell Stem Cell Volume 14, Issue 3, Pages (March 2014) DOI: /j.stem
Nuclear Receptors, RXR, and the Big Bang Ronald M. Evans, David J. Mangelsdorf Cell Volume 157, Issue 1, Pages (March 2014) DOI: /j.cell
ERBB Receptors: From Oncogene Discovery to Basic Science to Mechanism-Based Cancer Therapeutics Carlos L. Arteaga, Jeffrey A. Engelman Cancer Cell Volume.
The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes Tae-Min Kim, Peter W. Laird, Peter J. Park Cell Volume 155, Issue.
The Good Fat Cell Volume 147, Issue 7, (December 2011) DOI: /j.cell Copyright © 2011 Terms and Conditions Terms and Conditions.
Shaping Genetic Alterations in Human Cancer: The p53 Mutation Paradigm Thierry Soussi, Klas G. Wiman Cancer Cell Volume 12, Issue 4, Pages (October.
Sensory Detection of Food Rapidly Modulates Arcuate Feeding Circuits Yiming Chen, Yen-Chu Lin, Tzu-Wei Kuo, Zachary A. Knight Cell Volume 160, Issue 5,
Normal and Leukemic Stem Cell Niches: Insights and Therapeutic Opportunities Koen Schepers, Timothy B. Campbell, Emmanuelle Passegué Cell Stem Cell Volume.
Sex-Specific Aging in Flies, Worms, and Missing Great-Granddads
Kenneth L. Scott, Scott Powers  Cancer Cell 
An Alternative Sugar Fuels AML
The Evolution of the Algorithms for Collective Behavior
Gerry P. Crossan, Juan I. Garaycoechea, Ketan J. Patel  Cell Stem Cell 
Deregulating EMT and Senescence: Double Impact by a Single Twist
The Cell Cycle: Now Live and in Color
Human Telomerase Caught in the Act
Not All DDRs Are Created Equal: Non-Canonical DNA Damage Responses
The AML Salad Bowl Cancer Cell
In This Issue Cell Volume 158, Issue 5, (August 2014)
Hopping between Differentiation States in Lung Adenocarcinoma
Gliomas “Dope Up” for Growth
Dynamics of an Aging Genome
Volume 36, Issue 1, Pages 2-14 (October 2009)
Heike Döppler, Peter Storz  Cell Metabolism 
Field Cancerization: Something New Under the Sun
Cancer Genomes Evolve by Pulverizing Single Chromosomes
Keeping the Beat in the Rising Heat
It’s a SMAD/SMAD World Cell
A Biomarker Harvest from One Thousand Cancer Cell Lines
Deregulating EMT and Senescence: Double Impact by a Single Twist
Hypoxia-Inducible Factors, Stem Cells, and Cancer
Cancer Evolution: No Room for Negative Selection
Volume 152, Issue 1, (January 2013)
Lung Cancer: A Wily Genetic Opponent
Translational Control by the Eukaryotic Ribosome
The Ribosome Emerges from a Black Box
Volume 130, Issue 6, (September 2007)
Picking Pyknons out of the Human Genome
Kenneth L. Scott, Scott Powers  Cancer Cell 
Volume 143, Issue 6, (December 2010)
NO Signals from the Cancer Stem Cell Niche
How to Survive Aneuploidy
The Cell Biology of Genomes: Bringing the Double Helix to Life
Pluripotency without Proliferation
Cancer Evolution during Immunotherapy
To Infinium, and Beyond! Cancer Cell
Volume 163, Issue 4, (November 2015)
Nicholas McGranahan, Charles Swanton  Cancer Cell 
Volume 163, Issue 2, (October 2015)
Navigating the Deubiquitinating Proteome with a CompPASS
Volume 134, Issue 6, (September 2008)
Ibrutinib Treatment of CLL: The Cancer Fights Back
In This Issue Cell Volume 145, Issue 3, (April 2011)
The AML Salad Bowl Cancer Cell
Notching Up MYC Gives a LIC
Volume 148, Issue 1, (January 2012)
Targeting Protein Stability with a Small Molecule
No Driver behind the Wheel? Targeting Transcription in Cancer
Presentation transcript:

Telomeres and Cancer: From Crisis to Stability to Crisis to Stability Peter J. Campbell  Cell  Volume 148, Issue 4, Pages 633-635 (February 2012) DOI: 10.1016/j.cell.2012.01.043 Copyright © 2012 Elsevier Inc. Terms and Conditions

Figure 1 The Telomere Crisis Model of Cancer Evolution Cancers initially evolve slowly, gradually acquiring spontaneous mutations (yellow dots). With increasing numbers of cell divisions, however, telomeres erode, and this induces a rapid increase in both the number of mutations (red dots) and the subclonal heterogeneity in the organ. Out of these competing subclones, one emerges with more malignant potential. As Ding et al. (2012) show, it is to this clone's selective advantage to re-establish genomic stability through re-expression of telomerase. A period of relative genomic stability may follow, but this equilibrium can be disrupted by inhibition of telomerase. Hu et al. (2012) find that, after initial therapeutic benefit, such inhibition induces a second telomere crisis, again with rapid acquisition of new mutations (green dots) and subclonal heterogeneity. Cell 2012 148, 633-635DOI: (10.1016/j.cell.2012.01.043) Copyright © 2012 Elsevier Inc. Terms and Conditions